chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Pyrexia
Clinical narrative: fever; shivering; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of fever in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular, unknown deltoid) .5 ml. On an unknown date, an unknown time after receiving Shingrix, the patient experienced fever (Verbatim: fever) and shivering (Verbatim: shivering). The outcome of the fever and shivering were resolved (duration 24 hrs).   It was unknown if the reporter considered the fever and shivering to be related to Shingrix.     It was unknown if the company considered the fever and shivering to be related to Shingrix.   Additional Information: GSK Receipt Date: 16-OCT-2024 The reporter was the patient, a retired pharmacist.  He received his first Shingrix dose about one to two months ago.  The pharmacy did not give the patient a vaccine card/lot. He had shivering and a fever for about 24 hours post-vaccination and then the symptoms resolved. Nothing else was reported. The reporter did not consent to follow-up.
Age: 0.83
Sex: U
Vaccine: DTAPIPV
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: I found this article on the website but am unable to open it ; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 10-month-old patient who received DTPa-IPV (Kinrix) for prophylaxis.   On 16-OCT-2024, the patient received Kinrix. On 16-OCT-2024, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: I found this article on the website but am unable to open it). The outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 17-OCT-2024 The reporter was trying to find information about article, which led to inappropriate age at vaccine administration. The reporter found this article on the website but am unable to open it inadvertent Use of Kinrix in children younger than 4 Years of Age or Older than 6 Years of Age. No additional demographic details for patient. The reporter consented to follow up.
Sex: M
Vaccine: MMR
Symptoms: Incorrect route of product administration
Clinical narrative: inadvertently given the Priorix IM instead of SubQ; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of subcutaneous injection formulation administered by other route in a 35-year-old male patient who received MMR (Priorix) (batch number D2LP3, expiry date 01-DEC-2024) for prophylaxis.   On 16-OCT-2024, the patient received Priorix (intramuscular). On 16-OCT-2024, an unknown time after receiving Priorix, the patient experienced subcutaneous injection formulation administered by other route (Verbatim: inadvertently given the Priorix IM instead of SubQ). The outcome of the subcutaneous injection formulation administered by other route was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 17-OCT-2024 The reporter reported that a patient was inadvertently given the Priorix IM instead of SubQ, which led to subcutaneous injection formulation administered by other route. The reporter consented to follow up. No further details provided.
Sex: F
Vaccine: HEP
Symptoms: Expired product administered
Clinical narrative: female patient received on September 6th 2024 a dose of Engerix B expired on August 12th 2024.; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 28-year-old female patient who received HBV (Engerix B) (batch number 4JG5Y, expiry date 12-AUG-2024) for prophylaxis.   On 06-SEP-2024, the patient received the 1st dose of Engerix B. On 06-SEP-2024, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: female patient received on September 6th 2024 a dose of Engerix B expired on August 12th 2024.). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 17-OCT-2024 The reporter reported that they had just realized that a patient received Engerix B expired and wanted to know how to proceed, which led to expired vaccine used. The reporter did not consent to follow-up. The Vaccine Administration Facility was the same as Primary Reporter.
Sex: M
Vaccine: VARZOS
Symptoms: Extra dose administered
Clinical narrative: Extra dose given; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 61-year-old male patient who received Herpes zoster (Shingrix) (batch number 425CR, expiry date 10-AUG-2026) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 01-NOV-2022, batch number: BH5G2) and Shingrix (received 2nd dose on 01-JAN-2023 , batch number: 3922H).   On 17-OCT-2024, the patient received the 3rd dose of Shingrix. On 17-OCT-2024, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: Extra dose given). The outcome of the extra dose administered was unknown.   Additional Information: GSK Receipt Date: 17-OCT-2024 A pharmacist contacted GSK to request information about the administration for 3rd dose of Shingrix to a patient, which led to extra dose administered. They requested safety information. The reporter consented to follow up.  The Vaccine Administration Facility was the same as Primary Reporter.
Sex: U
Vaccine: UNK
Symptoms: Product storage error
Clinical narrative: vaccine stored outside recommended conditions and administered to patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in a patient who received Flu Seasonal TIV Dresden (Fluarix 2024-2025 season) (batch number 7554T, expiry date 30-JUN-2025) for prophylaxis.   On an unknown date, the patient received Fluarix 2024-2025 season. On an unknown date, an unknown time after receiving Fluarix 2024-2025 season, the patient experienced incorrect storage of drug (Verbatim: vaccine stored outside recommended conditions and administered to patient). The outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 18-OCT-2024 The reporter reported that that they had a refrigerator that went out of temperature range and, it did not get super-hot before they set it, but a number of these Fluarix were given after the temperature excursion which led to, incorrect storage of drug. The vaccine was out of storage conditions that was 56°F for 135 hours. The pharmacist said that the vaccines were given to 17 patients, but he gave the initials of 20 patients. HCP (Healthcare professional) did not have the gender nor the DOB (Date of birth) of the patients at the time of the call. HCP was not sure which patients got the doses before the maximum cumulative time of the extended stability data was reached. This was 1 of 20 linked report, reported by same reporter.; Sender's Comments:  US-GSK-US2024128771:same reporter/different patient US-GSK-US2024128730:same reporter/different patient US-GSK-US2024128754:same reporter/different patient US-GSK-US2024128724:same reporter/different patient US-GSK-US2024128727:same reporter/different patient US-GSK-US2024128739:same reporter/different patient US-GSK-US2024128736:same reporter/different patient US-GSK-US2024128763:same reporter/different patient US-GSK-US2024128758:same reporter/different patient US-GSK-US2024128760:same reporter/different patient US-GSK-US2024128741:same reporter/different patient US-GSK-US2024128719:same reporter/different patient US-GSK-US2024128756:same reporter/different patient US-GSK-US2024128716:same reporter/different patient US-GSK-US2024128734:same reporter/different patient US-GSK-US2024128740:same reporter/different patient US-GSK-US2024128750:same reporter/different patient US-GSK-US2024128747:same reporter/different patient US-GSK-US2024128774:same reporter/different patient US-GSK-US2024128767:same reporter/different patient US-GSK-US2024128767:same reporter/different patient
Sex: U
Vaccine: UNK
Symptoms: Product storage error
Clinical narrative: Vaccine stored outside recommended conditions and administered to patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in a patient who received Flu Seasonal TIV Dresden (Fluarix 2024-2025 season) (batch number 7554T, expiry date 30-JUN-2025) for prophylaxis.   On an unknown date, the patient received Fluarix 2024-2025 season. On an unknown date, an unknown time after receiving Fluarix 2024-2025 season, the patient experienced incorrect storage of drug (Verbatim: Vaccine stored outside recommended conditions and administered to patient). The outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 18-OCT-2024 The reporter reported that that they had a refrigerator that went out of temperature range and, it did not get super-hot before they set it, but a number of these Fluarix were given after the temperature excursion which led to, incorrect storage of drug. The vaccine was out of storage conditions that was 56°F for 135 hours. The pharmacist said that the vaccines were given to 17 patients, but he gave the initials of 20 patients. HCP (Healthcare professional) did not have the gender nor the DOB (Date of birth) of the patients at the time of the call. HCP was not sure which patients got the doses before the maximum cumulative time of the extended stability data was reached. This was 1 of 20 linked report, reported by same reporter. ; Sender's Comments:  US-GSK-US2024128736:same reporter/different patient US-GSK-US2024128760:same reporter/different patient US-GSK-US2024128758:same reporter/different patient US-GSK-US2024128754:same reporter/different patient US-GSK-US2024128739:same reporter/different patient US-GSK-US2024128771:same reporter/different patient US-GSK-US2024128727:same reporter/different patient US-GSK-US2024128763:same reporter/different patient US-GSK-US2024128724:same reporter/different patient US-GSK-US2024128730:same reporter/different patient US-GSK-US2024128740:same reporter/different patient US-GSK-US2024128741:same reporter/different patient US-GSK-US2024128719:same reporter/different patient US-GSK-US2024128767:same reporter/different patient US-GSK-US2024128716:same reporter/different patient US-GSK-US2024128756:same reporter/different patient
Age: 84.0
Sex: M
Vaccine: RSV
Symptoms: Syringe issue, Underdose
Clinical narrative: she was giving an Arexvy vaccine and had a bad needle & syringe set, and at least half of the vaccine leaked out.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of accidental underdose in a 84-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 7427S, expiry date 12-OCT-2025) for prophylaxis.   On 18-OCT-2024, the patient received Arexvy. On 18-OCT-2024, an unknown time after receiving Arexvy, the patient experienced accidental underdose (Verbatim: she was giving an Arexvy vaccine and had a bad needle & syringe set, and at least half of the vaccine leaked out.). The outcome of the accidental underdose was unknown.   Additional Information: GSK Receipt Date:18-OCT-2024 The reporter stated that she was giving an Arexvy vaccine and had a bad needle and syringe set, and at least half of the vaccine leaked out, which led to accidental underdose. The reporter consented to follow up via postal.  The Vaccine Administration Facility was the same as Primary Reporter.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Rash, Urticaria
Clinical narrative: "rashes" or "hives" 2 to 3 days after receiving the vaccine/"started on my head. Work down to the extremities, down to my feet; "rashes" or "hives" 2 to 3 days after receiving the vaccine/"started on my head. Work down to the extremities, down to my feet; Felt miserable; This spontaneous case was reported by a patient and describes the occurrence of RASH ("rashes" or "hives" 2 to 3 days after receiving the vaccine/"started on my head. Work down to the extremities, down to my feet), URTICARIA ("rashes" or "hives" 2 to 3 days after receiving the vaccine/"started on my head. Work down to the extremities, down to my feet) and FEELING ABNORMAL (Felt miserable) in a 69-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. 8058877) for COVID-19 prophylaxis.     No Medical History information was reported.    On 24-Oct-2023, the patient received fifth dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. In October 2023, the patient experienced RASH ("rashes" or "hives" 2 to 3 days after receiving the vaccine/"started on my head. Work down to the extremities, down to my feet), URTICARIA ("rashes" or "hives" 2 to 3 days after receiving the vaccine/"started on my head. Work down to the extremities, down to my feet) and FEELING ABNORMAL (Felt miserable). The patient was treated with Cetirizine hydrochloride (Zyrtec) at an unspecified dose and frequency and Carbidopa, Levodopa (Tidomet) at an unspecified dose and frequency. At the time of the report, RASH ("rashes" or "hives" 2 to 3 days after receiving the vaccine/"started on my head. Work down to the extremities, down to my feet), URTICARIA ("rashes" or "hives" 2 to 3 days after receiving the vaccine/"started on my head. Work down to the extremities, down to my feet) and FEELING ABNORMAL (Felt miserable) outcome was unknown.            The concomitant medication was not reported by reporter.  The patient was administered the Spikevax 2023-2024 vaccine on 24-OCT-2023. She had rashes or hives 2 to 3 days post-vaccination and felt miserable. The symptoms reportedly began on the head and progressed to the extremities, ultimately reaching the feet. To alleviate these symptoms, the patient was prescribed Zyrtec and Tidomet, which provided relief within one hour. However, the patient noted that the symptoms recurred whenever the medications were discontinued, persisting for a duration of two weeks.   This case was linked to US-MODERNATX, INC.-MOD-2024-776037 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2024-776037:Other peoples case
Age: 59.0
Sex: M
Vaccine: VARZOS
Symptoms: Loss of consciousness, Syncope
Clinical narrative: felt unconscious; fainted; This serious case was reported by a consumer and described the occurrence of unconscious in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 16th June 2024).   On 22-OCT-2024, the patient received the 2nd dose of Shingrix. On 23-OCT-2024, 1 days after receiving Shingrix, the patient experienced unconscious (Verbatim: felt unconscious) (serious criteria GSK medically significant) and fainting (Verbatim: fainted) (serious criteria GSK medically significant). The outcome of the unconscious and fainting were not reported.   It was unknown if the reporter considered the unconscious and fainting to be related to Shingrix.     The company considered the unconscious and fainting to be unrelated to Shingrix.   Additional Information: GSK Receipt Date: 24-OCT-2024 The patient was the reporter. The reporter reported that an adverse event happened after receiving the Shingrix vaccine. The patient was doing sex with partner and felt unconscious and fainted on partner after taking vaccine.; Sender's Comments: Loss of consciousness  and Syncope are unlisted events which are considered unrelated to GSK vaccine Shingrix.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Peripheral swelling, Pyrexia, Sciatica
Clinical narrative: CHILLS, COMPLETE SORENESS OF MY BODY AND HAND SWELLING. HAD A FEVER THE NIGHT I GOT THE SHOT. I STILL HAVE ALL THE SAME SYMPTOMS EVEN AFTER ALMOST 3 WEEKS SINCE THE SHOT. ADDITIONALLY CONCURRENTLY I GOT SCIATICA IN MY LEFT LEG WHEN I NEVER GET IT THERE. ALWAYS ON MY RIGHT LEG...I JUST THINK THE DOOR OPENED WITH THE SORENESS OF THE BODY WHERE SCIATICA CAME ON...
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Swelling
Clinical narrative: The vaccine against varicela was administered to an infant patient and around 5 minutes later it was observed the area red and swollen. Dr. was notified; who evaluated the patient and prescribed Benadryl and Bactroban.
Age: 50.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Brain fog, Dizziness, Fatigue, Formication, Headache
Clinical narrative: Skin crawling, dizziness, BPV, face tingling, brain fog, fatigue, HAs
Age: 50.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Paraesthesia, Vertigo positional
Clinical narrative: Skin crawling, dizziness, BPV, face tingling, brain fog, fatigue, HAs
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Non-Hodgkin's lymphoma
Clinical narrative: I had the Covid Pfizer vaccine back in 2021 and then I believe I got Moderna booster in 2022. In 2023, I got diagnosed with non-hodgkin's lymphoma. I can't be certain that the vaccine caused it, but I didn't have any risk factors and no family history. I'm reporting in case you need to investigate.
Sex: F
Vaccine: COVID19-2
Symptoms: Blood test, Central nervous system function test, Electrocardiogram, Fatigue, Headache
Clinical narrative: Finally, yesterday I was given a diagnosis of POTS, resulting from the COVID Vaccinations. I had all 3 Pfizer vaccinations as soon as they became available to me. Since then I have experienced syncope and actual passing out, horrible headaches, insomnia, severe fatigue, and more. These issues caused a serious decline in my quality of life. Years of tests and thousands of dollars have gone into coming up with this diagnosis. I believe the information that this is happening to many thousands of us is being kept secret. I have been undergoing tests since a year ago. I have had, tilt table, ekg, ecg, blood work, sonogram, bloodwork, neurological testing, and scans (brain and heart) and other tests I have certainly forgotten.
Sex: F
Vaccine: COVID19-2
Symptoms: Insomnia, Loss of consciousness, Postural orthostatic tachycardia syndrome, Quality of life decreased, Scan
Clinical narrative: Finally, yesterday I was given a diagnosis of POTS, resulting from the COVID Vaccinations. I had all 3 Pfizer vaccinations as soon as they became available to me. Since then I have experienced syncope and actual passing out, horrible headaches, insomnia, severe fatigue, and more. These issues caused a serious decline in my quality of life. Years of tests and thousands of dollars have gone into coming up with this diagnosis. I believe the information that this is happening to many thousands of us is being kept secret. I have been undergoing tests since a year ago. I have had, tilt table, ekg, ecg, blood work, sonogram, bloodwork, neurological testing, and scans (brain and heart) and other tests I have certainly forgotten.
Sex: F
Vaccine: COVID19-2
Symptoms: Scan brain, Syncope, Tilt table test, Ultrasound scan
Clinical narrative: Finally, yesterday I was given a diagnosis of POTS, resulting from the COVID Vaccinations. I had all 3 Pfizer vaccinations as soon as they became available to me. Since then I have experienced syncope and actual passing out, horrible headaches, insomnia, severe fatigue, and more. These issues caused a serious decline in my quality of life. Years of tests and thousands of dollars have gone into coming up with this diagnosis. I believe the information that this is happening to many thousands of us is being kept secret. I have been undergoing tests since a year ago. I have had, tilt table, ekg, ecg, blood work, sonogram, bloodwork, neurological testing, and scans (brain and heart) and other tests I have certainly forgotten.
Age: 32.0
Sex: M
Vaccine: MNQ
Symptoms: Product storage error
Clinical narrative: Patient status post splenectomy. Due to post splenectomy vaccines. Patient going to get Menveo but upon questioning found out that the vaccine had been unprotected from light. When looking up vaccine in system advises to protect from light. This prompted a call to the manufacturer (GSK). Manufacturer also advised that the product needs to be protected from light and not to use product if unprotected from light for any period of time. Concern is that the box of the product does not designate to protect form light leading to storage issues once at our facility. Wondering if adding protect from light would help to stop patients from getting vaccine that is no longer effective as if it's not protected from light the product degrades.
Age: 20.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: *Moderna 2023-2024 Covid-19 vaccine given to client with no advere reactions noted. I was informed by RE-(Regional Entity) at DSHS Immunizations on 9/24/24 (by email) that any client receiving covid 2023-2024 after 8/22/24 would need a VAERS report.
Sex: M
Vaccine: MNQ
Symptoms: Aggression, Autism spectrum disorder, Condition aggravated, Irritability
Clinical narrative: Increase signifiant in ASD sx of aggression and poor self regulation, plus marked increase in irritability during waking forms. Started day after vacinnes and lasted 5-7 days.
Age: 44.0
Sex: M
Vaccine: COVID19, FLU3
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: *Moderna (Spikevax) 2023-2024 series given to client with no adverse reactions. was notified by health department on 9/24/24 (by email) that anyone receiving Covid19 2023-2024 after 8/22/24 will need to create a VAERS report.
Age: 39.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: Moderna Covid-19 (2023-2024) series given to client with no adverse reactions. I was informed by email from health department on 9/24/24 that any client who received covid-19 2023-2024 after 8/22/24 will need a VAERS report to be done.
Age: 19.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: Moderna Covid-19 2023-2024 series given to client with no adverse reactions. I was informed by health department that on 9/24/24 (by email) than any client recieving Covid-19 2023-2024 after 8/22/24, will need a VAERS report to be done.
Age: 66.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: No adverse event
Clinical narrative: Moderna (Spikevax) 2023-2024 series given to client with no adverse reactions. Was notified by health department that on 9/24/24 (by email) that clients who received COVID (2023-2024) after 8/22/24 will need to create a VAERS report. Moderna vaccine immediately removed from stock/inventory.
Age: 54.0
Sex: M
Vaccine: COVID19, FLU3
Symptoms: No adverse event
Clinical narrative: Moderna (Spikevax) 2023-2024 series given to client with no adverse reactions. I was notified by regional entity (RE) Agency  Immunizations on 9/24/24 (by email) then any clients receiving Covid-19 (2023-2024) after 8/22/24 will need to create a VAERS report. Moderna vaccine immediately received from stock.
Age: 59.0
Sex: M
Vaccine: COVID19, FLU3
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: Moderna (Spikevax) 2023-2024 series given to client with no adverse reactions. I was informed by Regional entity (RE), DSHS Immunizations on 9/24/24 (by email) that any client receiving covid-9 (2023-2024) after 8/22/24 will need a VAERS report. Moderna vaccine immediately removed from stack.
Age: 43.0
Sex: M
Vaccine: COVID19, FLU3
Symptoms: No adverse event
Clinical narrative: Moderna Covid 19 Spikevax 2023-2024 given to client w/ no adverse reaction noted. I was informed by RE at Agency Immunization on 9/24/24 (by email) that any client receiving Covid-19 2023-2024 after 8/22/24 will need a VAER report done.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Post herpetic neuralgia
Clinical narrative: Patient with history of shingles infection reported concern to primary care office 10/30/24, evaluated 11/1/24 by Dr., described as postherpetic neuralgia, Dr. offered to treat the pain with lidocaine gel, requested follow-up on symptoms and might offer oral medication.
Age: 1.17
Sex: M
Vaccine: DTAPIPVHIB, HEPA, VARCEL
Symptoms: Blister, Full blood count abnormal, Oral mucosal blistering, Pyrexia, Viral infection
Clinical narrative: Patient reports fever, blisters with water sacs on the feet, thighs, mouth and back
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Rash
Clinical narrative: Rash that started on midsection of patient's body.  Rash spread to neck and arms.
Age: 1.0
Sex: M
Vaccine: HEPA, MMRV
Symptoms: Pyrexia, Rash, Rash erythematous, Rash macular
Clinical narrative: Fevers up to 102-103 on 10/30 and on 11/01 a macular red rash more in neck and face but also in chest and back
Age: 66.0
Sex: M
Vaccine: MMR
Symptoms: Injection site mass, Injection site pain, Lymphadenopathy, Pyrexia
Clinical narrative: Fever of 103 for 3 days, swollen lymph node on arm that received vaccination, lump and pain at injection site.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Nausea, Pain in extremity, Paraesthesia
Clinical narrative: Paresthesias of fingers, pain of the right upper arm, nausea after receiving flu shot
Age: 15.0
Sex: F
Vaccine: FLU3
Symptoms: Feeling hot, Hyperhidrosis, Loss of consciousness, Pallor, Skin laceration
Clinical narrative: Patient about 45 minutes after vaccine, was checking out with her mom and sister at the grocery store. She passed out and hit her chin. She was out for a couple of minutes, sweaty, hot, very pale. She had to go to the hospital and get stitches in her chin.
Age: 15.0
Sex: F
Vaccine: FLU3
Symptoms: Suture insertion
Clinical narrative: Patient about 45 minutes after vaccine, was checking out with her mom and sister at the grocery store. She passed out and hit her chin. She was out for a couple of minutes, sweaty, hot, very pale. She had to go to the hospital and get stitches in her chin.
Age: 0.08
Sex: F
Vaccine: DTPPVHBHPB, PNC20, RV1
Symptoms: Circumstance or information capable of leading to medication error
Clinical narrative: The Vaxelis, Prevnar 20, Rotarix vaccines WERE NOT ORDERED by the provider; the medical assistant gave the vaccines without the provider knowledge, consent or authorization.
Age: 8.0
Sex: F
Vaccine: FLU3
Symptoms: Circumstance or information capable of leading to medication error, No adverse event
Clinical narrative: No adverse event noted. Flu vaccine was given to this patient in a school flu clinic without a parent's consent. The classroom teacher discovered the wrong student was sent to the school flu clinic with another student's flu form and received the injection. The teacher notified the school nurse. The school nurse notified administration, the student's parent listed above, and the Health Unit. No treatment needed. No adverse reaction noted. Outcome: the school will make changes in the upcoming school year for flu clinic's: all students who  receive the vaccine will have name tags and the school nurse will be present the entire time while student's are receiving their injections. Protocol from the Department of Health was implemented per med error policy.
Age: 14.0
Sex: F
Vaccine: FLU3
Symptoms: Extra dose administered, No adverse event
Clinical narrative: I was at school doing a school flu clinic. Patient sat down to receive flu shot with her signed influnza consent form in hand.  I asked Patient name and DOB. Flu shot was given. After I had already left the school for the day, patient notifed the School Nurse RN that she had received her flu vaccine at her PCP's office. Patient never reported this to me before the flu shot was administered.  I verified in Web databse, she did receive her flu shot on 10/17/2024 at family practice. Web database was unavailable for me to verify before child received her flu shot today. School Nurse montitored child for any adverse reactions.
Age: 5.0
Sex: F
Vaccine: MMRV
Symptoms: Rash, Rash pruritic
Clinical narrative: Patient's mother contacted HU on 10/30/24 regarding her daughter's receipt of an MMRV vaccine on Monday 10/28/24. The child's mother stated that the child had developed a small rash Monday night after receipt of her immunization and the rash had steadily worsened. Mother stated it was mainly on her arms except for a small stretch across her lower back and the child complained that it was itchy.  CDNS advised that there is a risk of rash development after administration of MMRV and the rash could be related to either the measles component of the varicella component of the vaccine. Mother was educated on the need (per CDC recommendation found on the MMRV VIS) for the child to refrain from contact with infants and those with weakened immune systems until the rash goes away d/t the potential for spread of Varicella to unprotected individuals if the rash was related to the Varicella component. CDNS also advised on need to follow up with healthcare provider if child developed further symptoms such as fever or continued worsening of rash. Follow up phone call to child's mother was made on 10/31/24-Mom states rash is slightly better today and that she has been giving her allergy medication which seems to be helping.
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Chest pain, Computerised tomogram thorax, Electrocardiogram, Liver function test
Clinical narrative: chest pain that feels like it's going to explode. It fluctuates in intensity but always has some pain. It started the morning after getting the vaccine and now has lasted 10 days. sometimes OTC pain meds help but most of the time they dont.
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: Scan with contrast, Ultrasound abdomen
Clinical narrative: chest pain that feels like it's going to explode. It fluctuates in intensity but always has some pain. It started the morning after getting the vaccine and now has lasted 10 days. sometimes OTC pain meds help but most of the time they dont.
Age: 34.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Erythema, Pruritus, Urticaria
Clinical narrative: Onset of itchy, red hives first on arm of injection site, about 12hrs following injection. Over following 3 days, hives and reaction then spread to left arm, torso, and hands.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Malaise
Clinical narrative: Father states patient was really sick. Could not go to school or participate in sports.
Age: 8.0
Sex: M
Vaccine: TDAP
Symptoms: Dizziness, Headache, Injection site pain, Malaise, Pyrexia
Clinical narrative: 10/30/24  evening: post vaccination very sore arm at injection site. 10/31/24   Felt "ill" all day with Headache, fever,  light head ness and dizzy.  Fever peaked at 104 degrees Fahrenheit.   11/1/24 symptoms continued. He refused Tylenol. Applied warm compresses to injection site.  Gradually improved over the weekend. 11/4/24  back to normal activities.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema
Clinical narrative: Redness of injection site.
Age: 11.0
Sex: M
Vaccine: FLU3, HEPA, MNQ, TDAP, VARCEL
Symptoms: Syncope
Clinical narrative: Patient came to health department to receive school immunizations. The vaccinations were administered at 11:30am. During his observation time (12:15p-12:30p), he was alert, oriented, and coherent. He went to sit with his family in the lobby, at that time writer was alerted by a co-worker that he was not speaking. At 12:35pm, writer came to the lobby to assess him, he had a syncopal episode; vital signs were: 98.6-65-102/62-16-100%RA, he was easily aroused. His position was changed, and his legs were elevated. Patient stated he was thirsty and hungry; he was provided water and nourishment.  At the 12:45pm, the Nurse Practitioner was notified, assessed the patient. Vital signs were reassessed: 95-16-126-88-100%RA. 12:55pm Vitals were assessed: 77-16-112/75-100%RA, patient was able to sit up independently, fully alert and oriented, and engage in a conversation. The parents were thankful. No further issues noted.
Age: 6.0
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Dizziness, Headache, Injection site discomfort, Injection site erythema, Injection site pain
Clinical narrative: 10/30/24 evening:  Increasing discomfort at injection site.  Pain , redness and swelling. 10/31/24 morning felt "ill" all day.  Headache,  malaise, light headiness, dizziness, fever as high as 104 degrees Fahrenheit reported by mother.  11/1/24 symptoms continued and improved over the weekend. 11/4/24  symptoms resolved and back to normal activities.
Age: 6.0
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Injection site swelling, Malaise, Pyrexia
Clinical narrative: 10/30/24 evening:  Increasing discomfort at injection site.  Pain , redness and swelling. 10/31/24 morning felt "ill" all day.  Headache,  malaise, light headiness, dizziness, fever as high as 104 degrees Fahrenheit reported by mother.  11/1/24 symptoms continued and improved over the weekend. 11/4/24  symptoms resolved and back to normal activities.
Age: 76.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Mobility decreased
Clinical narrative: Difficulty raising arm for about a week; injection site red and small sore @ injection site
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: chest pains the night following the vaccine
Age: 5.0
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Dizziness, Headache, Injection site discomfort, Injection site pain, Injection site reaction
Clinical narrative: 10/30/24 evening:  Increasing discomfort at injection site.  Pain , redness and swelling. 10/31/24 morning felt "ill" all day.  Headache,  malaise, light headiness, dizziness, fever as high as 104 degrees Fahrenheit reported by mother.  11/1/24 symptoms continued and Red, raised rash developed on both arms.  All symptoms improved over the weekend. 11/4/24  symptoms resolved and back to normal activities.
Age: 5.0
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Injection site swelling, Malaise, Pyrexia, Rash, Rash erythematous
Clinical narrative: 10/30/24 evening:  Increasing discomfort at injection site.  Pain , redness and swelling. 10/31/24 morning felt "ill" all day.  Headache,  malaise, light headiness, dizziness, fever as high as 104 degrees Fahrenheit reported by mother.  11/1/24 symptoms continued and Red, raised rash developed on both arms.  All symptoms improved over the weekend. 11/4/24  symptoms resolved and back to normal activities.
Age: 5.0
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Rash papular
Clinical narrative: 10/30/24 evening:  Increasing discomfort at injection site.  Pain , redness and swelling. 10/31/24 morning felt "ill" all day.  Headache,  malaise, light headiness, dizziness, fever as high as 104 degrees Fahrenheit reported by mother.  11/1/24 symptoms continued and Red, raised rash developed on both arms.  All symptoms improved over the weekend. 11/4/24  symptoms resolved and back to normal activities.
Age: 46.0
Sex: F
Vaccine: VARCEL
Symptoms: Chills, Erythema, Hyperhidrosis, Induration, Peripheral swelling
Clinical narrative: After vaccine my reaction started around 1 am on the 4th of October. My right arm swelled up and started getting red, hard and hot all down my left arm to my elbow, that lasted over 1 week.  At 1 am on the 4th I started getting chills and sweats.
Age: 46.0
Sex: F
Vaccine: VARCEL
Symptoms: Skin warm
Clinical narrative: After vaccine my reaction started around 1 am on the 4th of October. My right arm swelled up and started getting red, hard and hot all down my left arm to my elbow, that lasted over 1 week.  At 1 am on the 4th I started getting chills and sweats.
Age: 4.0
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Dizziness, Headache, Injection site discomfort, Injection site erythema, Injection site pain
Clinical narrative: 10/30/24 evening:  Increasing discomfort at injection site.  Pain , redness and swelling. 10/31/24 morning felt "ill" all day.  Headache,  malaise, light headiness, dizziness,  "mild" fever  reported by mother. Tylenol given .  11/1/24 symptoms continued with Red, Raised rash appearing on both arms.  All Symptoms improved over the weekend. 11/4/24  symptoms resolved and back to normal activities.
Age: 4.0
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Injection site swelling, Malaise, Pyrexia, Rash, Rash erythematous
Clinical narrative: 10/30/24 evening:  Increasing discomfort at injection site.  Pain , redness and swelling. 10/31/24 morning felt "ill" all day.  Headache,  malaise, light headiness, dizziness,  "mild" fever  reported by mother. Tylenol given .  11/1/24 symptoms continued with Red, Raised rash appearing on both arms.  All Symptoms improved over the weekend. 11/4/24  symptoms resolved and back to normal activities.
Age: 4.0
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Rash papular
Clinical narrative: 10/30/24 evening:  Increasing discomfort at injection site.  Pain , redness and swelling. 10/31/24 morning felt "ill" all day.  Headache,  malaise, light headiness, dizziness,  "mild" fever  reported by mother. Tylenol given .  11/1/24 symptoms continued with Red, Raised rash appearing on both arms.  All Symptoms improved over the weekend. 11/4/24  symptoms resolved and back to normal activities.
Age: 3.0
Sex: F
Vaccine: PNC20
Symptoms: Extra dose administered, No adverse event
Clinical narrative: nurse gave an extra dose of P20-no adverse outcome.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Adult dose of COVID-19 vaccine given to a child. No significant reaction/side effects.
Age: 88.0
Sex: F
Vaccine: FLU3
Symptoms: Candida infection, Injection site erythema, Pruritus
Clinical narrative: pt states as she was going to bed her left arm became very itchy. She had a dark pink area below the injection site. Then the dark pink area came up on her right arm along with the itching.  This reaction only lasted through the night. The following night she had the dark pink areas and itching came back on her arms, then her torso, her breast, back and her lower legs. She went to a Urgent Care.  BP and temp were normal She was prescribed anti-fungal cream clotrimazedole.  Was diagnosed with Candidiasis of the Skin. These symptoms would keep coming on her body during the nights but would dissappear during the day time. She said is was so strange that it would come and go and only be present at night. Symptoms were gone by 11/2/24.  She also contacted the pharmacy to let them know.  Will contact her HCP to let them know.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Dizziness
Clinical narrative: Dizziness,weakness
Age: 0.33
Sex: F
Vaccine: DTAPIPVHIB, PNC20, RV1
Symptoms: Diarrhoea
Clinical narrative: Diarrhea (isolated)
Age: 82.0
Sex: F
Vaccine: FLU3
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient received two Fluad vaccinations on 8/21/2024 and 10/31/2024. No adverse reactions noted per patient.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Resident developed a 14cm x 15cm red, warm to touch area on vaccine site. Denies pain, complaints of itching at site. Physician notified New order for ice pack and monitoring of site.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Limb injury, Periarthritis, Product administered at inappropriate site
Clinical narrative: Vaccine was placed into the ball joint of my shoulder, injuring my shoulder and causing frozen shoulder
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity
Clinical narrative: left arm is still sore 3+ weeks after injection.  there is no redness or swelling but the area in/around shoulder joint is sore (muscle aches like someone punched me in the arm).  Range of motion is not restricted but is affected by symptoms (it's sore to lift arm all the way up).  have tried ibuprofen and naproxen - neither were effective.
Age: 10.0
Sex: M
Vaccine: FLU3
Symptoms: No adverse event
Clinical narrative: None. No adverse reactions.
Age: 72.0
Sex: F
Vaccine: COVID19, FLU3
Symptoms: Pain in extremity
Clinical narrative: Sore arm reported to continue 40 days after receiving vaccine
Age: 73.0
Sex: M
Vaccine: COVID19, FLU3
Symptoms: Pain in extremity
Clinical narrative: Sore arm continuing 40 days after vaccine administration
Age: 64.0
Sex: F
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: Reported to office on 9/27/24 with complaints of receiving Flu Vaccine on 9/2/2024 and breaking out in hives within 36 hours following vaccine. She did not seek treatment until the OV on 9/27/24 and at that time Prednisone, Vistaril and Famotidine started. Reported back to office on 10/10/24 and hives resolved while taking Prednisone. Reported back to the office on 10/24/24 with complaints of since completing Prednisone the hives returned and come and goes to different locations of body. Cimetidine started on 10/24/24. Reported back to the office on 10/31/24 and had complete resolution of hives since starting on Cimetidine.
Age: 37.0
Sex: M
Vaccine: FLU3
Symptoms: C-reactive protein normal, Headache, Injection site erythema, Injection site warmth, Mobility decreased
Clinical narrative: Reported righted shoulder pain within 1 day of IM influenza vaccination.  States difficulty raising arm, no numbness or tingling except with vigorious range of motion. Initial assessment showed vaccine site is red and warm. States headache initially but denied any other systemic symptoms.  Ibuprofen and benadryl ordered.  Ice to area.
Age: 37.0
Sex: M
Vaccine: FLU3
Symptoms: X-ray
Clinical narrative: Reported righted shoulder pain within 1 day of IM influenza vaccination.  States difficulty raising arm, no numbness or tingling except with vigorious range of motion. Initial assessment showed vaccine site is red and warm. States headache initially but denied any other systemic symptoms.  Ibuprofen and benadryl ordered.  Ice to area.
Age: 48.0
Sex: M
Vaccine: FLU3
Symptoms: Joint swelling
Clinical narrative: swollen right knee. Ortho administered Cortisone injection that did not help. 20 days later associate revived a "gel shot" that helped.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Pruritus, Urticaria
Clinical narrative: Hives all over my body, achy joints, overall fatigue.  City walk-in clinic recommended Zyrtec, which I have been taking.  I'm also applying cortisone cream to the hive that itch most.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Dose incorrect, adult dose given to pediatric patient. No side effects/adverse effects
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Lymphadenopathy, Pain in extremity
Clinical narrative: L axillary LAD and L arm pain
Age: 68.0
Sex: M
Vaccine: TDAP
Symptoms: Rash
Clinical narrative: Pt called stating she has a rash in both arm pits, neck, and chest.  Pt instructed to take Benadryl to help with the rash and to inform her md
Age: 0.33
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Mobility decreased, Musculoskeletal stiffness
Clinical narrative: Patient had right shoulder pain and stiffness along with decreased range of motion beginning within 12 hours of receiving the vaccine.
Age: 76.0
Sex: M
Vaccine: FLU3
Symptoms: Extra dose administered, Wrong product administered
Clinical narrative: Patient presented to clinic for covid vaccine but was given fluzone HD in error by LPN. Patient had already received the flu shot the day prior at a different facility
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Product administered at inappropriate site
Clinical narrative: Red, Swollen and warm to touch area on the lower left arm about half way between her elbow and shoulder. Reaction developed the next day after receiving vaccine in office on 10/29/24. Per FNP, injection reaction she suspects is due to incorrect placement of administration.  She recommended for patient to take 50 mg of Benadryl, apply ice to the area and inform the office if redness spreads any larger which was outlined by a surgical marker.
Age: 5.0
Sex: M
Vaccine: COVID19, FLU3
Symptoms: Extra dose administered, Product administered to patient of inappropriate age
Clinical narrative: During a flu/covid clinic during clinic hours the family came in to get all three of their children vaccinated. Vaccines were discussed with family and ordered. Two nursing staff came back into room and although each of the children's vaccines were separated on individual trays the one of the twin 5 year olds received their siblings vaccines an additional flu shot for the season as well as the 6mo-4 year covid vaccine. Family was notified at time of incident.
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Constipation, Headache, Incontinence, Migraine, Mobility decreased
Clinical narrative: Migraine within 1 hour of shot, incontinence, constipation, low grade fever, nausea, terrible body aches all week. Friday woke up and could not move neck and was in a lot of pain in neck and head.    That lasted 24 hours.  By Saturday 10 am, felt fine.  Like nothing had happened.  I have not ever had a reaction to the yearly flu shot.  So perplexed.
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Nausea, Neck pain, Pain, Pyrexia
Clinical narrative: Migraine within 1 hour of shot, incontinence, constipation, low grade fever, nausea, terrible body aches all week. Friday woke up and could not move neck and was in a lot of pain in neck and head.    That lasted 24 hours.  By Saturday 10 am, felt fine.  Like nothing had happened.  I have not ever had a reaction to the yearly flu shot.  So perplexed.
Age: 67.0
Sex: M
Vaccine: COVID19, FLU3
Symptoms: Guillain-Barre syndrome
Clinical narrative: Diagnosed Guillain-Barré
Age: 44.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: Arm pain
Age: 65.0
Sex: F
Vaccine: FLU3, PNC20
Symptoms: Immediate post-injection reaction, Injection site discolouration, Injection site nodule
Clinical narrative: After administering vaccine, patient immediately had knot form.  There was no redness at injections site, just bluish discoloration.  I had patient apply an ice pack and after 15 minutes patient reported that they were feeling fine and patient did not see any change in size of swelling.  They will continue to monitor and we will follow up in 24 hours
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site mass, Injection site pruritus, Injection site swelling
Clinical narrative: Pt called pharmacy 11/4/24 to report injection site reaction. She states there is a "knot" at site of injection that's raised, swelling and itchy. At time of phone call, she said knot had subsided a bit over the past few days, but itchiness and redness still remain. I explained types of injection site reactions and let her know not to scratch or irritate the area further, she can take NSAID to help with swelling and ice the area in 5 minute increments to reduce swelling.
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: High dose given instead of regular dose.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: The patient had an appointment for a flu vaccine. Received the Covid vaccine instead.  Mother brought patient back once she realized which vaccine she had received. Patient then received the flu vaccine.